Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

MSD wins FDA approval for cholesterol pill to help plug Keytruda void

MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.

Latest news

Novo secures European approval for oral Wegovy to extend lead over Lilly

Novo Nordisk is relying on first-mover advantage in the obesity pill arena to close the gap on Eli Lilly.

Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

This acquisition marks Lilly’s first move into the psychedelic space as the pharma curates a diversified pipeline.

UK commits to pharma IP protection in Swiss trade deal

The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement

JCVI issues recommendation on adolescent MenB vaccination in UK

The JCVI review incorporated recent data on the effectiveness in adolescents vaccinated against MenB in infancy.

Bayer’s heart failure drug bound for NHS on NICE recommendation

Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

FDA grants traditional approval to Novartis’ Fabhalta for IgAN

The traditional FDA approval was supported by results from the Phase III APPLAUSE-IgAN study.